레나임
1 known investors
Renaim (레나임) is a strategic R&D company focused on the bench-to-market development of genomics-based pharmaceuticals. It develops biopharmaceuticals through open innovation partnerships with specialized R&D firms, covering research, clinical development, and regulatory approval.